AtriCure (ATRC) - EV/EBITDA Multiple

AtriCure Medical - graphic logo of issuer ATRC

AtriCure, Inc. (ATRC) creates a niche dominance effect through its narrow specialization in atrial fibrillation therapy. The EV/EBITDA value, accounting for total debt, clearly demonstrates this market position, with the metric holding at 72.50. Growth is driven by billion-dollar investments in cryoablation and minimally invasive instrumentation. Simultaneously, AtriCure, Inc. (ATRC) is implementing energy-saving technologies and eco-packaging, optimizing production to meet strict ESG standards.

ATRC AtriCure Corp: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/10/2026

Analytical breakdowns for atricure.com (ATRC)

- stock price and consensus target price:
Stock Quotes AtriCure Corp|ATRC - Fair Value Consensus
- market capitalization indicators:
Market Capitalization AtriCure Medical|ATRC - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share AtriCure|ATRC - Accounting Capitalization|Market Value to Book Value Ratio atricure.com|ATRC - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Equity Ratio AtriCure, Inc.|ATRC - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity AtriCure|ATRC - Aggregate Debt Obligations|Debt to Book Value AtriCure Medical|ATRC - Company Long-Term Debts|Company Short-Term Debt AtriCure|Quick Ratio atricure.com
- business earnings and investment ratios data:
ATRC - Company Net Income|Expected Profit AtriCure, Inc.|ATRC - Price to Earnings Multiple|Projected Price to Earnings AtriCure, Inc.|ATRC - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AtriCure Medical|ATRC - Operating income before deduction of amortization|Net earnings per share (EPS TTM) AtriCure|ATRC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months atricure.com|ATRC - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year AtriCure, Inc.
Summary company analysis:AtriCure Corp (ATRC)
Manufactured products of AtriCure

This multiple compares the total enterprise value, including net debt, with operating profitability, allowing for the determination of the asset's real price regardless of the financing structure. Analyzing the EV/EBITDA ratio helps assess the effectiveness of AtriCure, Inc. (ATRC) expansion into global markets and the rising demand for arrhythmia treatment tools, eliminating the risk of overpaying for capitalization.

Competitors of AtriCure, Inc.

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|STAAR Surgical Company (STAA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ChromaDex|ZIMV (ZimVie) - EV/EBITDA Multiple|Company Value to EBITDA AngioDynamics Inc ANGO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerus Corp (CERS)|Teknova Inc - Enterprise Value to Operating Income Before Depreciation|Monogram Technologies - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio STSS (Sharps Technology Inc)|INFU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Utah Medical Products Inc. UTMD|KRMD: EV/EBITDA Multiple|Nyxoah S.A (NYXH) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MBOT|PDEX (pro-dex.com) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zentek (ZTEK)|ELUT (Elutia Inc) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple MLSS (Milestone Scientific Corp)|Total Company Value to Operating Income Before Depreciation Ratio NEXGEL Inc (NXGL)|Retractable Tech - EV/EBITDA Multiple|Harvard Bioscience Inc. (HBIO) - Enterprise Value to EBITDA Ratio|FEMY (Femasys) - Enterprise Value to EBITDA Ratio|Meihua Medical Technologies Co., Ltd. (MHUA) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Predictive Oncology Inc|CJMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATRI|NURO - Company Value to EBITDA